UPDATES FROM IDG
DRGC, KMC, RDOC, CEIT

NEWS HIGHLIGHTS

This month we have a role-reversal (it's your turn to email 🙂) with NIH's posting of a RFI concerning IDG digitial resources; announcement of keynote speaker for 2021 meeting; sharing of new IDG publications and reminder of funding opportunities.
Hope all are safe and well.

NIH has announced a Request For Information (RFI) for "Input on Improvements to the Illuminating the Druggable Genome (IDG) Program’s Digital Resources" (NOT-RM-20-018). This request covers both Pharos and DruggableGenome.net website with aims including improvements to the user experience and outreach of IDG digital resources. Please note the due date for responses is July 20, 2020.

We encourage our readers to review this RFI and share it with colleagues. And we very much appreciate if you could take some time to give feedback by emailing responses to DruggableGenome@nih.gov, per instructions of the RFI.

2021 IDG meeting

Dr. Lily Jan and Dr. Bryan Roth are co-organizers for a FASEB summer research conference entitled "The Understudied Druggable Proteome Conference", scheduled for August 8-13, 2021 in Snowmass, CO. Keynote speaker will be Dr. Ardem Patapoutian, a 2020 KavliPrize laureate in neuroscience, for discovering sensory receptors for temperature and pressure, as well as pain.

For more information on this FASEB meeting, please visit this link

IDG publications

Nature Reviews Drug Discovery - KNa1.1 channels as a target for treating early-onset epilepsy. doi: 10.1038/d41573-020-00092-2

Nature Chemical Biology - TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. doi: 10.1038/s41589-020-0535-8

NIH funding opportunities

The second round of IDG associated R03's are still open for submission. Check out NIH's RFA: "Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)" (RFA-RM-20-019), with Letter of Intent due June 15, 2020 and grant submission due July 15, 2020.

Find us online

DRGC: U24 DK116195, U24 DK116204, U24 DK116214
KMC: U24 CA224370, U24 CA224260; RDOC: U24 TR002278
CEIT: U01 CA239106, U01 CA239108, U01 CA239069
More IDG details on our IDG site or via NIH Common Fund site.

DruggableGenome Twitter

Pharos Twitter

YouTube

view this email in your browser

Copyright © 2020, RDOC part of IDG, All rights reserved.
IDG Newsletter Vol. 9, 2020-05-01

Our email address is: idg.rdoc@gmail.com

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this? unsubscribe from this list update subscription preferences
Illuminating the Druggable Genome · 1 University of New Mexico · Albuquerque, NM 87131-0001 · USA